Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Studies whether hepatitis B affects the course of inflammatory bowel disease

Looks at how hepatitis B infection relates to inflammatory bowel disease in adults.

Plain-language title generated from the registry record
Registry title: Impact of Hepatitis B Virus on Inflammatory Bowel Disease

Key facts

Where
Tanta, EgyptSee the site

Where in Egypt

  • Tanta University HospitalsTanta, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Tanta University
Trial code
NCT06881238
Record updated
18 March 2025
Original description
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients.Read full original descriptionShow less

The Impact of Hepatitis B Virus Infection on the Clinical Course of Inflammatory Bowel Disease in Egyptian Patients

The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients.

Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection.

Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.

Inclusion: Male or female patients older than 18 years; Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.

Exclusion: Patients aged < 18 years; Unwilling to participate in our study.

ClinicalTrials.gov NCT06881238